Olux Drug Patent Profile
✉ Email this page to a colleague
When do Olux patents expire, and what generic alternatives are available?
Olux is a drug marketed by Mylan and is included in two NDAs. There are two patents protecting this drug and one Paragraph IV challenge.
The generic ingredient in OLUX is clobetasol propionate. There are fourteen drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Olux
A generic version of Olux was approved as clobetasol propionate by COSETTE on February 16th, 1994.
Summary for Olux
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 80 |
Patent Applications: | 4,476 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for Olux |
What excipients (inactive ingredients) are in Olux? | Olux excipients list |
DailyMed Link: | Olux at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for Olux
Paragraph IV (Patent) Challenges for OLUX
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
OLUX | Topical Foam | clobetasol propionate | 0.05% | 021142 | 1 | 2005-06-27 |
US Patents and Regulatory Information for Olux
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan | OLUX | clobetasol propionate | AEROSOL, FOAM;TOPICAL | 021142-001 | May 26, 2000 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Mylan | OLUX E | clobetasol propionate | AEROSOL, FOAM;TOPICAL | 022013-001 | Jan 12, 2007 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Mylan | OLUX E | clobetasol propionate | AEROSOL, FOAM;TOPICAL | 022013-001 | Jan 12, 2007 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Olux
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Mylan | OLUX | clobetasol propionate | AEROSOL, FOAM;TOPICAL | 021142-001 | May 26, 2000 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Olux
See the table below for patents covering Olux around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Slovakia | 283049 | ⤷ Try a Trial | |
Czech Republic | 9702758 | ⤷ Try a Trial | |
European Patent Office | 0813413 | MOUSSE CONTENANT UN CORTICOSTEROIDE (CORTICOSTEROID-CONTAINING FOAM) | ⤷ Try a Trial |
China | 1179720 | ⤷ Try a Trial | |
Denmark | 0813413 | ⤷ Try a Trial | |
Poland | 322088 | ⤷ Try a Trial | |
Czech Republic | 285913 | Farmaceutická kompozice obsahující kortikosteroid (PHARMACEUTICAL COMPOSITION CONTAINING CORTICOSTEROID) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |